At Shire, our ability to embrace change and adapt has always been key to our success. We actively look for partners to help us grow our business. As part of our goal to bring innovative treatments to address unmet patient needs, Shire engages in a number of partnerships with leading academic centers, technology providers, and biotechnology companies. These partnerships enable Shire to access a wide range of innovation aligned with our strategic needs and combine the expertise of our partners with Shire's development and commercialization capabilities.

By putting great minds together, we strive to facilitate the development of life changing therapies. To contact us about possible collaborations, email us at rarediseaseresearch@shire.com.

Innovation Series

Shire actively seeks collaboration opportunities with leading clinicians, researchers, and new technology platforms in areas of high unmet need. This is a video series demonstrating how Shire is focused on moving our pipeline forward through external collaborations, acquisitions, and in-house expertise. This potent combination of various areas of expertise throughout the R&D lifecycle is intended to accelerate development and deliver more therapies to patients - faster.

We partner with hospitals, in-license molecules, engage in dedicated ways with charitable foundations, acquire compounds and experts and champion a robust in-house R&D program.

Learn more about how we create and collaborate as we start to unveil Shire's Innovation Series, a collection of videos designed to shine a light on some of the work - and partners - we are really proud of.